Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

End-to-End Pathology and POCT Managed Services

Active
International

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract for End-to-End Pathology and POCT Managed Services, issued by Supply Chain Coordination Limited, focuses on delivering comprehensive diagnostic outcomes for prime contractors on NHS Supply Chain projects. The scope of work encompasses the entire diagnostic cycle, including preanalytical, analytical, and postanalytical phases, to ensure a fully operational managed pathology service. A key objective is the expansion of diagnostic capabilities into neighborhood settings and Community Diagnostic Centres through the implementation of Point of Care Testing devices and integrated workflow systems. The provider is responsible for maintaining strict clinical performance and quality assurance standards across all service areas. Interested parties must note that the response deadline for this opportunity is December 16, 2026. The contract is categorized under NAICS code 621511, emphasizing the specialized medical laboratory nature of the required services.

General Info

Subcontract for NHS pathology and POCT managed services, deadline December 16, 2026.

Place of Performance

GBR

Set-Aside

NONE

Documents

This scope was carved out of Project_1717.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

In-Vitro Diagnostics, Point of Care Testing & Pathology Services

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencySupply Chain Coordination Limited
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Performs end-to-end pathology and Point of Care Testing (POCT) outcomes for prime contractors on NHS Supply Chain projects. Manages the full diagnostic cycle including preanalytical, analytical, and postanalytical phases. Expands diagnostics into Community Diagnostic Centres (CDCs) and neighborhood settings using POCT devices and integrated workflow systems. Maintains clinical performance and quality assurance standards. Delivers a fully operational managed pathology service.

Similar Contracts

Same NAICS industry code

NAICS: 621511
New
Federal
Q301--NEW – STX Specialized Molecular Residual Disease Testing
Solicitation # 36C25727Q0058
The Department of Veterans Affairs, Network Contracting Office 17, intends to award a sole-source, Indefinite Delivery Indefinite Quantity (IDIQ) Firm-Fixed-Price contract to Natera, Inc. for proprietary molecular genetic reference testing services. These services are essential for evaluating and monitoring transplant patients and cancer residual disease through the use of the Prospera molecular expression transplant assessment test and the Signatera Residual Disease Test (MRD). The government has identified Natera, Inc. as the sole provider because they possess the exclusive proprietary methodologies, assays, and bioinformatics platforms required to perform these specific tests, with no authorized distributors or alternative clinical sources available. The scope of work includes an estimated quantity of 35 Signatera tests (CPT Codes 81479, 81455) and 25 Prospera tests (CPT Code 81479). The contract will span five ordering periods, with performance taking place at VA facilities within VISN 17 in Texas. While this notice is not a formal request for quotes, interested parties may submit capability statements to Susan Flores by November 2, 2026, to demonstrate the existence of an equivalent proprietary test. The government retains discretion on whether to compete the requirement based on the responses received.
257-NETWORK Contract Office 17 (36C257)

POSTED

about 23 hours ago

DEADLINE

in 10 days
View Details
NAICS: 621511
New
SLED
Personnel- ALEA Drug Screening
Solicitation # SRC0000037283
This solicitation, identified as SRC0000037283, is for the provision of a comprehensive drug testing and screening program for the Alabama Law Enforcement Agency (ALEA). The scope of work includes the administration of various drug screens, such as hair analysis via LabCorp PSC, non-NIDA panel 8 tests, and saliva testing, along with the provision of test kits. Additionally, the contractor is responsible for providing a two-hour online reasonable suspicion training session compliant with DOT and Drug Free Workplace regulations, managing random selection processes, and performing medical reviews of non-negative results. The contract is processed as a Quick Quote through the Alabama Buys system, with the State of Alabama reserving the right to evaluate bids based on cost realism and price reasonableness. The resulting contract may be renewed annually for a total period of up to five years, with a total cost cap of 25,000 dollars. Key compliance requirements include mandatory enrollment in E-Verify for suppliers with employees in Alabama, registration with the Alabama Secretary of State for foreign entities, and strict adherence to state tax certifications under Section 41-4-142 of the Code of Alabama 1975. Legal venue for any disputes is established in the City of Montgomery, Alabama. Suppliers must submit all responses electronically via the Alabama Buys portal and may be required to provide professional licenses, certificates of insurance, and manufacturer authorizations following the bid opening.
Personnel

POSTED

2 days ago

DEADLINE

in 4 days
View Details

More opportunities from Supply Chain Coordination Limited

Same awarding agency

New
International
In-Vitro Diagnostics, Point of Care Testing & Pathology Services
Solicitation # Project_1717
Supply Chain Coordination Limited is establishing a National Framework Agreement, identified as Project_1717, for the provision of In-Vitro Diagnostic Devices, Point of Care Testing products, and related pathology services across the United Kingdom. The scope is divided into three lots: Lot 1 focuses on end-to-end Pathology Managed Services to expand diagnostics into community settings; Lot 2 covers Pathology Software Solutions including AI platforms and middleware; and Lot 3 addresses Diagnostics Testing Solutions across various disciplines such as biochemistry, genomics, and haematology. The framework includes the supply of core laboratory equipment, consumables, reagent rental agreements, and specimen storage and collection services. The procurement is structured as an open framework with an overall intended duration of eight years, with the initial term running from October 18, 2027, to October 17, 2029. There is no limit on the number of suppliers who can be appointed. Award criteria vary by lot, with Lot 1 and 2 weighted at 80 percent for non-financial quality, 10 percent for social value, and 10 percent for price. Lot 3 is weighted at 60 percent for quality, 30 percent for cost, and 10 percent for social value. The authority may award contracts through the framework either with or without further competition. Small and medium-sized enterprises, as well as voluntary, community and social enterprises, are eligible to participate. The deadline for tender submissions is December 16, 2026.

POSTED

about 17 hours ago

DEADLINE

in about 2 months
View Details
NAICS: 339112
New
International
Total Orthopaedic Solutions 4
Solicitation # Project_1723
The Total Orthopaedic Solutions 4 framework, managed by Supply Chain Coordination Limited, is a procurement project for products and services used in orthopaedic, trauma, and spine procedures within the United Kingdom. The contract is divided into three lots: Lot 1 for implants and consumables, Lot 2 for orthopaedic equipment such as robotics and power tools, and Lot 3 for services and solutions including planning software and managed equipment servicing. The total estimated value of the framework is 3,071,000,000 GBP excluding VAT, with an estimated performance period running from February 1, 2028, to January 31, 2032. Awards will be made through a competitive process based on a weighted evaluation of ranked discount offerings (30%), efficiency (25%), purpose (15%), social value (10%), and patient, staff, and supply chain considerations (20%). Tenderers must meet rigorous compliance and certification standards to be eligible. Mandatory requirements include ISO 9001:2015, BS EN ISO 13485:2016, or MDAP accreditation, as well as CE Certification and Declarations of Conformity where applicable. Sustainability and ethical mandates include a Carbon Reduction Plan meeting PPN 006, an Evergreen Sustainable Supplier Assessment Level 1, and a Modern Slavery Assessment Tool score of 41% or higher. Additionally, suppliers handling patient data or providing IT systems must hold a Cyber Security Essentials Plus Certificate. All submissions must be made via the Jaggaer eTendering portal by December 14, 2026, and must be priced in sterling and written in English under the jurisdiction of English law.
Surgical and Medical Instrument Manufacturing

POSTED

4 days ago

DEADLINE

in about 2 months
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS